TECN Stock Overview
Provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Tecan Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 240.00 |
| 52 Week High | CHF 392.00 |
| 52 Week Low | CHF 225.00 |
| Beta | 0.62 |
| 11 Month Change | -13.79% |
| 3 Month Change | -23.42% |
| 1 Year Change | -11.37% |
| 33 Year Change | -56.64% |
| 5 Year Change | 4.08% |
| Change since IPO | 411.73% |
Recent News & Updates
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable
Oct 09
These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well
Sep 21Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%
Aug 16Recent updates
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable
Oct 09These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well
Sep 21Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%
Aug 16Is Tecan Group (VTX:TECN) Using Too Much Debt?
Jun 14Calculating The Fair Value Of Tecan Group AG (VTX:TECN)
Apr 20Tecan Group AG's (VTX:TECN) Business Is Yet to Catch Up With Its Share Price
Apr 02Tecan Group (VTX:TECN) Could Easily Take On More Debt
Dec 05A Look At The Intrinsic Value Of Tecan Group AG (VTX:TECN)
Nov 15Tecan Group (VTX:TECN) Could Easily Take On More Debt
Sep 01Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 37% Above Its Share Price
Aug 11Tecan Group (VTX:TECN) Seems To Use Debt Rather Sparingly
May 26Why We Think Shareholders May Be Considering Bumping Up Tecan Group AG's (VTX:TECN) CEO Compensation
Apr 11Here's Why Tecan Group (VTX:TECN) Can Manage Its Debt Responsibly
Dec 02Is Tecan Group (VTX:TECN) Using Too Much Debt?
Sep 02Should You Be Adding Tecan Group (VTX:TECN) To Your Watchlist Today?
Jun 15Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?
Apr 04Tecan Group (VTX:TECN) Has Announced That It Will Be Increasing Its Dividend To CHF2.80
Mar 17With EPS Growth And More, Tecan Group (VTX:TECN) Is Interesting
Mar 09With EPS Growth And More, Tecan Group (VTX:TECN) Is Interesting
Nov 24Is Now The Time To Put Tecan Group (VTX:TECN) On Your Watchlist?
Aug 26Is Now The Time To Put Tecan Group (VTX:TECN) On Your Watchlist?
May 28Are Institutions Heavily Invested In Tecan Group Ltd.'s (VTX:TECN) Shares?
Mar 18Here's Why I Think Tecan Group (VTX:TECN) Might Deserve Your Attention Today
Feb 01Is Tecan Group's (VTX:TECN) 188% Share Price Increase Well Justified?
Jan 12What Type Of Shareholders Own The Most Number of Tecan Group Ltd. (VTX:TECN) Shares?
Dec 18Declining Stock and Solid Fundamentals: Is The Market Wrong About Tecan Group Ltd. (VTX:TECN)?
Nov 30Shareholder Returns
| TECN | CH Life Sciences | CH Market | |
|---|---|---|---|
| 7D | -9.4% | 3.7% | 1.1% |
| 1Y | -11.4% | 48.8% | 17.0% |
Return vs Industry: TECN underperformed the Swiss Life Sciences industry which returned 45.5% over the past year.
Return vs Market: TECN underperformed the Swiss Market which returned 15.5% over the past year.
Price Volatility
| TECN volatility | |
|---|---|
| TECN Average Weekly Movement | 7.2% |
| Life Sciences Industry Average Movement | 4.3% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.3% |
| 10% least volatile stocks in CH Market | 1.5% |
Stable Share Price: TECN's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: TECN's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 3,000 | Achim von Leoprechting | www.tecan.com |
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution.
Tecan Group AG Fundamentals Summary
| TECN fundamental statistics | |
|---|---|
| Market cap | CHF 3.08b |
| Earnings (TTM) | CHF 101.34m |
| Revenue (TTM) | CHF 1.00b |
30.4x
P/E Ratio3.1x
P/S RatioIs TECN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TECN income statement (TTM) | |
|---|---|
| Revenue | CHF 1.00b |
| Cost of Revenue | CHF 653.34m |
| Gross Profit | CHF 346.71m |
| Other Expenses | CHF 245.37m |
| Earnings | CHF 101.34m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 12, 2025
| Earnings per share (EPS) | 7.90 |
| Gross Margin | 34.67% |
| Net Profit Margin | 10.13% |
| Debt/Equity Ratio | 17.8% |
How did TECN perform over the long term?
See historical performance and comparison